• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    5.18 Down 0.23(4.25%) Jan 30, 4:00PM EST
    |After Hours : 5.18 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:5.41
    Open:5.36
    Bid:5.01 x 300
    Ask:N/A
    1y Target Est:11.13
    Beta:1.66
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:5.16 - 5.49
    52wk Range:5.01 - 33.70
    Volume:493,754
    Avg Vol (3m):730,231
    Market Cap:216.06M
    P/E (ttm):19.33
    EPS (ttm):0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 4.25%216.06M
    NKTRDown 2.79%1.88B
    RHHBYDown 1.79%N/A
    SNSSUp 0.85%146.20M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.06
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback